The Covid kids starting school unable to speak
Children with speech problems could not access therapy during Covid – but now some are getting expert help.
Similar Posts
16 Products Under $25 That Are Shockingly Effective
As much as we love a good splurge every now and then, there’s nothing like getting your hands on a quality item that didn’t cost a fortune. But we all know that sometimes, a suspiciously affordable price tag can be a deterrent. What if the item doesn’t work, is cheap and breaks after just one…
Vertex shares pop after nonopioid painkiller posts positive midstage trial results
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019. Brian Snyder | Reuters Shares of Vertex Pharmaceuticals jumped Wednesday after the company’s painkiller, which is being tested as an alternative to opioids, significantly decreased pain in a midstage trial. Those positive results for diabetes patients suffering…
This Eco-Friendly Workout Gear Is Stylish And Sustainable
BuzzFeed may collect a share of sales or other compensation from the links on this page if you decide to shop from them. All products were independently selected by our editors, and the prices were accurate and items in stock at the time of publication. When the average person thinks about combating climate change, their…
Microplastics found in overwhelming majority of American meat, water, plants: study
A new study has found that the overwhelming majority of protein foods such as meat and fish are contaminated with microplastics. The comprehensive study, conducted by researchers at the nonprofit Ocean Conservancy, found that approximately 88% of protein samples tested contained microplastic particles. “Highly processed products contained the most microplastics per gram,” the study said…
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Monday said it will pay $2 billion in cash to acquire Ambrx Biopharma, a drugmaker specializing in one of the hottest areas of cancer treatment….
